C7B.8

Approximate Synonyms

• Cancer metastatic to abdomen

• Cancer metastatic to lung

• Cancer metastatic to mediastinum

• Neuroendocrine carcinoma metastatic to bilateral lungs

• Neuroendocrine carcinoma metastatic to left lung

• Neuroendocrine carcinoma metastatic to right lung

• Neuroendocrine tumor metastatic to dist lymph node

• Neuroendocrine tumor, metastatic

• Neuroendocrine tumor, metastatic to bone

• Neuroendocrine tumor, metastatic to liver

• Neuroendocrine tumor, metastatic to peritoneum

• Secondary neuroendocrine carcinoma of abdomen

• Secondary neuroendocrine carcinoma of bilateral lungs

• Secondary neuroendocrine carcinoma of bone

• Secondary neuroendocrine carcinoma of left lung

• Secondary neuroendocrine carcinoma of liver

• Secondary neuroendocrine carcinoma of lung

• Secondary neuroendocrine carcinoma of lymph node

• Secondary neuroendocrine carcinoma of mediastinum

• Secondary neuroendocrine carcinoma of peritoneum

• Secondary neuroendocrine carcinoma of right lung

• Secondary neuroendocrine carcinoma of unspecified site

Details

• C7B.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

• The 2023 edition of ICD-10-CM C7B.8 became effective on October 1, 2022.

• This is the American ICD-10-CM version of C7B.8 – other international versions of ICD-10 C7B.8 may differ.